325
Views
0
CrossRef citations to date
0
Altmetric
Letter to the editor

Letter to the editor regarding ‘Estetrol (E4): the new estrogenic component of combined oral contraceptives’

Page 1281 | Received 18 May 2020, Accepted 27 Aug 2020, Published online: 14 Oct 2020

References

  • Grandi G, Del Savio MC, Lopes da Silva Filho A, et al. Estetrol: the new estrogenic component of combined oral contraceptives. Expert Rev Clin Pharmacol. 2020;13(4):327–330.
  • Coelingh Bennink HJ, Skouby S. Bouchard P and Holinka C. Ovulation inhibition by estetrol in an in vivo model. Contraception. 2008;77:186–190.
  • Coelingh Bennink HJT, Holinka CF, Diczfalusy E, eds. Estetrol: vita nova for a fetal steroid. Climacteric. 2008;11Suppl. 1:1–72.
  • Visser M, Kloosterboer HJ, Coelingh Bennink HJ. Estetrol prevents and suppresses mammary tumors induced by DMBA in a rat model. Horm Mol Biol Clin Investig. 2012 Apr 1;9(1):95–103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.